Press "Enter" to skip to content

Sun Pharma gets 4 observations from USFDA for its Halol facility

The United States Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAl) of company’s Halol facility from June 3 to June 11, 2019, Sun Pharma said in a filing to the BSE.

Original source:

Also Read:   Pentagon looking to provide up to 100,000 body bags for civilians in virus outbreak